10035-41-3

Usage

Uses

As of now, there is insufficient information available in the provided materials to list specific applications for 2-Ethylbenzofuran-3-carbaldehyde. However, given its classification as a benzofuran, it may potentially be used in various chemical or pharmaceutical processes once its properties and potential uses are further explored and documented in scientific literature.

InChI:InChI=1/C11H10O2/c1-2-10-9(7-12)8-5-3-4-6-11(8)13-10/h3-7H,2H2,1H3

Upstream product

• 3131-63-3 2-ethylbenzofuran 
• 68-12-2 N,N-dimethyl-formamide 
• 1646-26-0 1-(benzo[b]furan-2-yl)ethanone 
• 4885-02-3 Dichloromethyl methyl ether 
• 271-89-6 1-benzofurane 
• 90-02-8 salicylaldehyde 

Downstream Products

• 102956-84-3 3t-(2-ethyl-benzofuran-3-yl)-1-(5-isopropyl-4-methoxy-2-methyl-phenyl)-propenone 
• 80079-25-0 2-ethyl-3-methylbenzofuran 
• 92287-69-9 2-ethyl-benzofuran-3-carbaldehyde oxime 
• 29936-00-3 6-(2-ethyl-benzofuran-3-yl)-4-morpholin-4-yl-1⁽⁵⁾,6-dihydro-[1,3,5]triazin-2-ylamine 
• 29936-01-4 N-[4-ethyl-5-(2-hydroxy-phenyl)-pyrimidin-2-yl]-morpholine-4-carboximidic acid amide 
• 1133-47-7 2-(3-ethyl-isoxazol-4-yl)-phenol 
• 92029-43-1 1-acetoxy-2-(3-ethyl-isoxazol-4-yl)-benzene 
• 88612-03-7 3-ethyl-4-(2-methoxy-phenyl)-isoxazole 
• 42901-97-3 2-ethyl-benzofuran-3-carbonitrile 

Relevant academic research and scientific papers

NOVEL COMPOUND AND PHARMACEUTICAL COMPOSITION COMPRISING SAME FOR ENHANCING ANTICANCER ACTIVITY

The present invention relates to a novel compound and a pharmaceutical composition for enhancing anticancer activity, which includes the same, and more particularly, to a pharmaceutical composition, which includes a compound represented by Formula 1 or a pharmaceutically acceptable salt thereof, thereby enhancing anticancer activity of an anticancer agent or radiation, and inducing proliferation inhibition and death of cancer cells, resulting in effectively treating cancer: In Formula 1, n is an integer of 0 to 4; R1 is hydrogen, C1 to C10 alkyl or aryl(C1 to C4)alkyl; R3 is C1 to C6 alkyl, and when there are a plurality of the R3, the R3s are the same or different; L1 is a direct bond, or C1 to C6 alkylene; R2 is hydrogen, C1 to C10 alkyl or aryl(C1 to C4)alkyl, and R4 is hydrogen, C1 to C4 alkyl, C3 to C8 cycloalkyl or aryl(C1 to C4)alkyl, or R2 and R4 are connected to form a 4 to 7-membered ring; and the alkyl of R1 to R4, the arylalkyl of R1, R2 and R4, the cycloalkyl of R4, the alkylene of L1 are each independently unsubstituted or substituted with a substituent such as a C1 to C6 alkyl group, a halo group, an aryl group, a haloalkyl group, a nitro group, a cyano group, an alkylthio group or an arylalkylthio group, and when the compound is substituted with a plurality of substituents, the substituents are the same or different.